DK0981349T3 - 5-alfa-pregnan-3-beta-ol-20-on-sulfat til behandling af tumorer og CNS sygdomme - Google Patents
5-alfa-pregnan-3-beta-ol-20-on-sulfat til behandling af tumorer og CNS sygdommeInfo
- Publication number
- DK0981349T3 DK0981349T3 DK98918789T DK98918789T DK0981349T3 DK 0981349 T3 DK0981349 T3 DK 0981349T3 DK 98918789 T DK98918789 T DK 98918789T DK 98918789 T DK98918789 T DK 98918789T DK 0981349 T3 DK0981349 T3 DK 0981349T3
- Authority
- DK
- Denmark
- Prior art keywords
- pregnan
- tumors
- beta
- alpha
- sulfate
- Prior art date
Links
- AURFZBICLPNKBZ-FZCSVUEKSA-N 3beta-hydroxy-5alpha-pregnan-20-one Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)C)[C@@]2(C)CC1 AURFZBICLPNKBZ-FZCSVUEKSA-N 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 title 1
- AURFZBICLPNKBZ-UHFFFAOYSA-N Pregnanolone Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(=O)C)C1(C)CC2 AURFZBICLPNKBZ-UHFFFAOYSA-N 0.000 title 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 title 1
- 208000015114 central nervous system disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US85056797A | 1997-05-02 | 1997-05-02 | |
| PCT/US1998/008456 WO1998050042A1 (en) | 1997-05-02 | 1998-04-28 | Pregnan-3-ol-20-ones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0981349T3 true DK0981349T3 (da) | 2003-03-10 |
Family
ID=25308504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98918789T DK0981349T3 (da) | 1997-05-02 | 1998-04-28 | 5-alfa-pregnan-3-beta-ol-20-on-sulfat til behandling af tumorer og CNS sygdomme |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0981349B1 (da) |
| JP (1) | JP2001525807A (da) |
| KR (1) | KR20010012157A (da) |
| CN (1) | CN1254283A (da) |
| AR (1) | AR012638A1 (da) |
| AT (1) | ATE227130T1 (da) |
| AU (1) | AU739146B2 (da) |
| BR (1) | BR9809376A (da) |
| CA (1) | CA2289006A1 (da) |
| DE (1) | DE69809223T2 (da) |
| DK (1) | DK0981349T3 (da) |
| ES (1) | ES2186153T3 (da) |
| PT (1) | PT981349E (da) |
| WO (1) | WO1998050042A1 (da) |
| ZA (1) | ZA983705B (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1270718C (zh) * | 1998-03-11 | 2006-08-23 | 托布乔恩·贝克斯托罗姆 | 表别孕烷醇酮在制备治疗甾族化合物诱导的疾病的药物中的应用 |
| SE0104423D0 (sv) | 2001-12-27 | 2001-12-27 | Umecrine Ab | Pregnane steroids and their use in the treatment of CNS disorders |
| US7572780B2 (en) | 2003-01-21 | 2009-08-11 | Dimera, Incorporated | Method and kit for reducing the symptoms of peripheral vascular disease |
| ATE499104T1 (de) | 2005-03-24 | 2011-03-15 | Univ Emory | Progesterone dosierungsanweisung in der behandlung einer traumatischen verletzung des gehirns |
| US7473687B2 (en) | 2005-03-24 | 2009-01-06 | Emory University | Methods for the treatment of a traumatic central nervous system injury |
| WO2006117592A1 (en) * | 2005-04-29 | 2006-11-09 | Inserm | Methods of modulating nuclear receptors |
| JP5687287B2 (ja) * | 2010-01-14 | 2015-03-18 | ウメクライン ムード エービー | 改善された保存性及び溶解特性を有する３−ベータ−ヒドロキシ−５−アルファ−プレグナン−２０−オンを含有する薬学的組成物 |
-
1998
- 1998-04-28 CN CN98804719A patent/CN1254283A/zh active Pending
- 1998-04-28 DK DK98918789T patent/DK0981349T3/da active
- 1998-04-28 KR KR19997010102A patent/KR20010012157A/ko not_active Withdrawn
- 1998-04-28 ES ES98918789T patent/ES2186153T3/es not_active Expired - Lifetime
- 1998-04-28 WO PCT/US1998/008456 patent/WO1998050042A1/en not_active Ceased
- 1998-04-28 JP JP54815598A patent/JP2001525807A/ja active Pending
- 1998-04-28 EP EP98918789A patent/EP0981349B1/en not_active Expired - Lifetime
- 1998-04-28 BR BR9809376-2A patent/BR9809376A/pt not_active IP Right Cessation
- 1998-04-28 PT PT98918789T patent/PT981349E/pt unknown
- 1998-04-28 CA CA002289006A patent/CA2289006A1/en not_active Abandoned
- 1998-04-28 AU AU71647/98A patent/AU739146B2/en not_active Ceased
- 1998-04-28 AT AT98918789T patent/ATE227130T1/de not_active IP Right Cessation
- 1998-04-28 DE DE69809223T patent/DE69809223T2/de not_active Expired - Fee Related
- 1998-04-30 AR ARP980102025A patent/AR012638A1/es unknown
- 1998-04-30 ZA ZA9803705A patent/ZA983705B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010012157A (ko) | 2001-02-15 |
| PT981349E (pt) | 2003-01-31 |
| DE69809223T2 (de) | 2003-07-24 |
| CN1254283A (zh) | 2000-05-24 |
| ATE227130T1 (de) | 2002-11-15 |
| JP2001525807A (ja) | 2001-12-11 |
| BR9809376A (pt) | 2000-07-04 |
| AU7164798A (en) | 1998-11-27 |
| AU739146B2 (en) | 2001-10-04 |
| AR012638A1 (es) | 2000-11-08 |
| WO1998050042A1 (en) | 1998-11-12 |
| DE69809223D1 (de) | 2002-12-12 |
| ZA983705B (en) | 1999-11-01 |
| CA2289006A1 (en) | 1998-11-12 |
| ES2186153T3 (es) | 2003-05-01 |
| EP0981349B1 (en) | 2002-11-06 |
| EP0981349A1 (en) | 2000-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO971015L (no) | Forbindelser og metoder for behandling av cancer | |
| NO991700D0 (no) | Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer | |
| DK1003479T3 (da) | Fremgangsmåde og sammensætninger til behandling af allergiske senfasereaktioner og inflammatoriske sygdomme | |
| DK1083889T3 (da) | Tetrahydronaphthalenforbindelser og deres anvendelse til behandling af neurodegenerative sygdomme | |
| NO20004098L (no) | FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser | |
| DK0971735T3 (da) | Fremgangsmåder og præparater til behandling af inflammatorisk tarmsygdom | |
| DK0830864T3 (da) | Kombinationsbehandling til behandling af psykoser | |
| DK0966447T3 (da) | Anvendelige små molekyler til behandling af betændelsessygdomme | |
| DK1033996T3 (da) | Forebyggelse og behandling af amyloidogen sygdom | |
| DK1094733T3 (da) | Fremgangsmåde til fremstilling af børstehårsvarer og børstehårsvarer fremstillet herefter | |
| DK1063990T3 (da) | Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser | |
| NO20012963L (no) | Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler | |
| DK0752870T3 (da) | Anvendelse af Mycobacterium til behandling af tumorer | |
| DK0831098T3 (da) | Mellemprodukter og fremgangsmåde til fremstilling af olanzapin | |
| IS5056A (is) | Ný meðhöndlun á liðbólgu | |
| ID27214A (id) | Triazolopiridina untuk pengobatan gangguan trombosis | |
| DK21795A (da) | Fremgangsmåde til fremstilling og oprensning af ioderede kontrastmidler | |
| NO994178L (no) | Atropisomere av 3-heteroaryl-4(3H)-kinazoloner for behandling av neurodegenerative og CNS-trauma-relaterte tilstander | |
| NO20002873L (no) | FremgangsmÕte for økning av produksjonen og forbedring av kvaliteten til sæd | |
| NO20001758D0 (no) | Fremgangsmåter og blandinger for behandling av leddgikt | |
| NO20003481D0 (no) | FremgangsmÕte for behandling av COPD | |
| DK1200447T3 (da) | Oxazinocarbazoler til behandling af CNS-sygdomme | |
| NO20012099D0 (no) | Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser | |
| IS5481A (is) | Samsett meðferð til meðhöndlunar á alnæmi | |
| DE69809223D1 (de) | 5-alpha-pregnan-3-beta-ol-20-one 3-sulfate für di behandlung von tumoren und zns krankheiten |